Christopher M Bailey (Christopher Bailey)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Top Venues

Cancer research communications

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Jonelle K Lee, Aditi Chatterjee, Mario Scarpa, Christopher M Bailey, Sandrine Niyongere, Prerna Singh, Moaath K Mustafa Ali, Shivani Kapoor, Yin Wang, Giovannino Silvestri, Maria R Baer
Pim kinase inhibitors increase gilteritinib cytotoxicity in FLT3-ITD acute myeloid leukemia through GSK-3β activation and c-Myc and Mcl-1 proteasomal degradation. Cancer research communications (2024)
Jonelle K Lee, Aditi Chatterjee, Mario Scarpa, Christopher M Bailey, Sandrine Niyongere, Prerna Singh, Moaath K Mustafa Ali, Shivani Kapoor, Yin Wang, Giovannino Silvestri, Maria R Baer
Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal Degradation. Cancer research communications 4 (2) (2024)
Jonelle K Lee, Aditi Chatterjee, Mario Scarpa, Christopher M Bailey, Sandrine Niyongere, Prerna Singh, Moaath K Mustafa Ali, Shivani Kapoor, Yin Wang, Giovannino Silvestri, Maria R Baer
Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal Degradation. Cancer research communications 4 (2) (2024)
Giovanni Damiani, Joselin D Tacastacas, Timothy Wuerz, Lindsay Miller, Philip Fastenau, Christopher M Bailey, Mansi Sethi Chawa, Amanda Argenas, Marco Fiore, Kevin D Cooper, Alan J Lerner
Cognition/Psychological Burden and Resilience in Cutaneous T-Cell Lymphoma and Psoriasis Patients: Real-Life Data and Implications for the Treatment. BioMed research international 2022 (2022)